Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental?
Authors
Taoreed Adegoke Azeez
Endocrinology, Metabolism and Diabetes Unit, Department of Medicine, University College Hospital, Ibadan, Nigeria
Sharif Adeniyi Folorunso
Department of Radiation Oncology, University College Hospital, Ibadan, Nigeria
Chinedu Eguzozie
Endocrinology, Metabolism and Diabetes Unit, Department of Medicine, University College Hospital, Ibadan, Nigeria
Adeleke Adedapo Adegboyega
Department of Clinical Pharmacology, University College Hospital, Ibadan, Nigeria
Language: English
Page range: 74 - 81
Submitted on: Aug 4, 2020
Accepted on: Sep 21, 2020
Published on: Aug 9, 2021
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2021 Taoreed Adegoke Azeez, Sharif Adeniyi Folorunso, Chinedu Eguzozie, Adeleke Adedapo Adegboyega, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.